We’re applying AI across the entire development lifecycle — from early research to commercial manufacturing — to shorten the time it takes to bring new medicines to market by up to one year. We’re aiming to triple the number of new medicines we launch, proof of our unwavering commitment to innovation.
At our newest Digital M&S Accelerator in Lyon (France), a cross-functional team of experts in data science, software engineering, and user experience working in a startup like…
Article Source
https://www.sanofi.com/en/magazine/our-science/a-new-era-of-biopharma-production-with-ai
